Thus, in this review, we summarize our current understanding of the interaction between nociceptors and, specifically, the myeloid cells of the innate immune system, while pointing out some of the ...

In this study, we characterized the soluble factors released by activated CAR-NK cells obtained from different sources and investigated their potential to induce bystander myeloid cell activation. We ...

1Laboratoire Réparation et Transcription dans les cellules Souches, Institut de Radiobiologie Cellulaire et Moléculaire, CEA/DRF/Jacob/IRCM, INSERM U1274, Université Paris-Saclay, Université ...

Researchers identify a pathogenic subset of CD8+ memory T-cells that promote airway tissue inflammation and recurrent ...

Nano-sized, tumor-targeting particles induced self-destruction of cancer cells in preclinical studies. A new twist on a ...

In vivo perturbations and single-cell RNA-seq reveal cell-type-specific STAT1-IFNg signaling in regulation of trained immunity in tissue-resident immune cells.

Medically reviewed by Doru Paul, MD Leukemia is a cancer of the blood-forming tissues that often develops in the bone marrow.

Novel CD37 antibody-drug conjugate shows promise in targeting the Achilles’ heel of acute myeloid leukemia cells.

Myeloid Therapeutics, Inc. ("Myeloid"), a clinical-stage immunology company advancing RNA therapeutics to conquer cancer, ...

MSK experts believe that giving the targeted drug asciminib to patients with chronic myeloid leukemia at the beginning of ...

Acute Myeloid Leukaemia (AML) with Retinoic acid receptor-gamma (RARG) fusions have similarities to Acute Promyelocytic Leukemia (APL) but are not responsive to standard APL treatments.